| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.048 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |